MindWalk Holdings (HYFT) Total Liabilities (2020 - 2026)
MindWalk Holdings (HYFT) posted quarterly Total Liabilities of $7.0 million for Q2 2026, down 51.99% year-over-year from $14.6 million in Q2 2025, and up 19.93% quarter-over-quarter from $5.9 million in Q1 2026.
MindWalk Holdings (HYFT) Total Liabilities (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Total Liabilities for 7 consecutive years, with $7.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Liabilities fell 51.99% year-over-year to $7.0 million; the TTM figure through Apr 2026 stood at $7.0 million (down 51.99% YoY), while the FY2026 annual figure was $7.0 million, down 53.0% from the prior year.
- Total Liabilities climbed to $7.0 million in Q2 2026 per HYFT's latest filing, from $5.9 million in the prior quarter.
- Across five years, Total Liabilities topped out at $44.6 million in Q1 2022 and bottomed at $5.9 million in Q1 2026.
- Historically, Total Liabilities has averaged $16.2 million across 5 years, with a median of $15.3 million in 2023.
- On a YoY basis, Total Liabilities climbed as much as 81.89% in 2022 and fell as far as 79.69% in 2022.
- MindWalk Holdings' Total Liabilities stood at $15.8 million in 2022, then advanced by 9.91% to $17.4 million in 2023, then increased by 14.92% to $20.0 million in 2024, then slumped by 69.71% to $6.1 million in 2025, then increased by 16.02% to $7.0 million in 2026.
- Business Quant data shows HYFT's Total Liabilities at $7.0 million in Q2 2026, $5.9 million in Q1 2026, and $6.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 384.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 7.02 Mn |
| Jan 31, 2026 | 5.86 Mn |
| Oct 31, 2025 | 6.05 Mn |
| Jul 31, 2025 | 14.56 Mn |
| Apr 30, 2025 | 14.63 Mn |
| Jan 31, 2025 | 14.38 Mn |
| Oct 31, 2024 | 19.98 Mn |
| Jul 31, 2024 | 19.31 Mn |
| Apr 30, 2024 | 17.93 Mn |
| Jan 31, 2024 | 21.36 Mn |
| Oct 31, 2023 | 17.39 Mn |
| Jul 31, 2023 | 17.04 Mn |
| Apr 30, 2023 | 14.79 Mn |
| Jan 31, 2023 | 15.83 Mn |
| Oct 31, 2022 | 15.82 Mn |
| Jul 31, 2022 | 10.65 Mn |
| Apr 30, 2022 | 14.50 Mn |
| Jan 31, 2022 | 44.60 Mn |
| Oct 31, 2021 | 47.99 Mn |
| Jul 31, 2021 | 52.45 Mn |